Mine Safety and Health Research Advisory Committee: Notice of Charter Renewal, 92818 [2016-30525]

Download as PDF 92818 Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices Reporting—Hospital, Version 1.2, as a starting point. AHRQ, in conjunction with community pharmacy representatives, designed these new formats to facilitate improved detection and understanding of medicationrelated events originating in pharmacies. If implemented as specified, the Common Formats— Community Pharmacy Version 1.0 will allow aggregation of medication-related data across different pharmacy providers. On October 6, 2015, AHRQ announced the availability of the— Common Formats Retail Pharmacy Version 0.1 Beta—for review and comment in the Federal Register (80 FR 60385–60387). After obtaining feedback from both the private and public sectors, the Agency finalized the format and renamed it Common Formats— Community Pharmacy Version 1.0. All elements—including the event description, aggregate reports, data elements and algorithms, and technical specifications—will be posted at the PSOPPC Web site: https:// www.psoppc.org/psoppc_web. More information on the Common Formats can be obtained through AHRQ’s PSO Web site: http:// www.pso.ahrq.gov/. Sharon B. Arnold, Deputy Director. [FR Doc. 2016–30604 Filed 12–19–16; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK3G9T082PROD with NOTICES Mine Safety and Health Research Advisory Committee: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Mine Safety and Health Research Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through November 30, 2018. For information, contact Jeffrey H. Welsh, B.A., Designated Federal Officer, Mine Safety and Health Research Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services, 626 Cochrans Mill Road, Mailstop P05, Pittsburgh, Pennsylvania 15236, Telephone (412) 386–4040 or fax (412) 386–6614. VerDate Sep<11>2014 19:36 Dec 19, 2016 Jkt 241001 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–30525 Filed 12–19–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee on Procedures Review (SPR), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee: Time and Date: 11:00 a.m.–4:30 p.m., EST, January 10, 2017 Place: Audio Conference Call via FTS Conferencing. Status: Open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dial-in number at 1–866–659– 0537 and the pass code is 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2016, pursuant to Executive Order 13708, and will expire on September 30, 2017. Purpose: The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. SPR was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. SPR is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU). Matters for Discussion: The agenda for the Subcommittee meeting includes: discussion of procedures in the following ORAU and DCAS technical documents: OCAS Technical Information Bulletin (TIB) 0013 and ORAUT Procedure 0042 (‘‘Individual Dose Adjustment Procedure for Y–12 Dose Reconstruction’’ and ‘‘Accounting for Incomplete Personal Monitoring Data on Penetrating Gamma-Ray Doses to Workers in Radiation Areas at the Oak Ridge Y–12 Plant Prior to 1961’’); Program Evaluation Report OCAS–PER– 011, (‘‘K–25 TBD and TIB Revisions’’), PER–055 (‘‘TBD 6000 Revisions’’), PER– 057 (‘‘General Steel Industries’’), PER 60 (‘‘Blockson Chemical Company’’), PER– 064 (‘‘DuPont Deep Water Works’’), and PER–066 (‘‘Huntington Pilot Plant’’), and a continuation of the commentresolution process for other dose E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Page 92818]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30525]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Mine Safety and Health Research Advisory Committee: Notice of 
Charter Renewal

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Mine Safety and Health Research 
Advisory Committee, Centers for Disease Control and Prevention, 
Department of Health and Human Services, has been renewed for a 2-year 
period through November 30, 2018.
    For information, contact Jeffrey H. Welsh, B.A., Designated Federal 
Officer, Mine Safety and Health Research Advisory Committee, Centers 
for Disease Control and Prevention, Department of Health and Human 
Services, 626 Cochrans Mill Road, Mailstop P05, Pittsburgh, 
Pennsylvania 15236, Telephone (412) 386-4040 or fax (412) 386-6614.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-30525 Filed 12-19-16; 8:45 am]
 BILLING CODE 4163-18-P